OPTiM: A randomized phase III trial of talimogene laherparepvec (T-VEC) versus subcutaneous (SC) granulocyte-macrophage colony-stimulating factor (GM-CSF) for the treatment (tx) of unresected stage IIIB/C and IV melanoma.-Reference-Cited by-同舟云学术

OPTiM: A randomized phase III trial of talimogene laherparepvec (T-VEC) versus subcutaneous (SC) granulocyte-macrophage colony-stimulating factor (GM-CSF) for the treatment (tx) of unresected stage IIIB/C and IV melanoma.

Published:2013-05-20 Issue:15_suppl Volume:31 Page:LBA9008-LBA9008
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Andtbacka Robert Hans Ingemar¹,Collichio Frances A.²,Amatruda Thomas³,Senzer Neil N.⁴,Chesney Jason⁵,Delman Keith A.⁶,Spitler Lynn E.⁷,Puzanov Igor⁸,Doleman Susan⁹,Ye Yining¹⁰,Vanderwalde Ari M.¹¹,Coffin Robert⁹,Kaufman Howard¹²

Affiliation:

1. Huntsman Cancer Institute, University of Utah, Salt Lake City, UT

2. The University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, NC

3. Hubert H. Humphrey Cancer Center, Robbinsdale, MN

4. Mary Crowley Cancer Research Center, Dallas, TX

5. University of Louisville, Louisville, KY

6. Department of Surgery, Emory University, Atlanta, GA

7. Northern California Melanoma Center, San Francisco, CA

8. Vanderbilt University Medical Center, Nashville, TN

9. Amgen, Inc., Woburn, MA

10. Department of Biostatistics and Epidemiology, Amgen Inc., South San Francisco, CA

11. Amgen, Inc., Thousand Oaks, CA

12. Rush University Medical Center, Chicago, IL

Abstract

LBA9008 The full, final text of this abstract will be available at abstract.asco.org at 7:30 AM (EDT) on Saturday, June, 1, 2013, and in the Annual Meeting Proceedings online supplement to the June 20, 2013, issue of Journal of Clinical Oncology. Onsite at the Meeting, this abstract will be printed in the Saturday edition of ASCO Daily News.

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modulation of Reoviral Cytolysis (II): Cellular Stemness;Viruses;2023-06-29

2. Image-Guided Intratumoral Delivery of Immunotherapeutics in Gastrointestinal Malignancies;Digestive Disease Interventions;2021-01-12

3. Future Directions and Challenges Facing Intralesional Immunotherapy With Talimogene Laherparepvec for Advanced Melanoma;Dermatologic Surgery;2021-01

4. Nanoparticles for the Treatment of Uveal Melanoma;Uveal Melanoma;2021

5. Immunotherapy;Practical Medical Oncology Textbook;2021